<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03728751</url>
  </required_header>
  <id_info>
    <org_study_id>FGCU IRB 2018-51</org_study_id>
    <nct_id>NCT03728751</nct_id>
  </id_info>
  <brief_title>Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System</brief_title>
  <official_title>Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Florida Gulf Coast University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Florida Gulf Coast University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessing for optimal time dry needles need to remain inside the body to have positive effect
      on the nervous system
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine what most optimal dry needling duration effect on
      the autonomic nervous system.

      Design: The researchers will conduct a pilot study to assess the effect of dry needling on
      the autonomic nervous system
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">October 29, 2018</completion_date>
  <primary_completion_date type="Actual">October 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single group pre-test post test study design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pupil diameter</measure>
    <time_frame>1.) 1 minute measure will be taken after accommodation of 2 minutes to the dark environment, 2.) needle placement and an immediate 1 minute second measure, 3.) every 2 minutes a measure of 1 minute to 8 post needle measures (24 minutes) total</time_frame>
    <description>Change in pupil diameter measured with automated pupillometry device from Micromedical.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study group receiving dry needling and pupil diameter will be studied up to 23 minutes after needle placement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dry needling</intervention_name>
    <description>Paravertebral dry needling C7-T4. Total of 8 needles.</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 18-65 years old

          2. No pain at all anywhere in the body at the time of testing.

          3. No caffeine containing products 3 hours before measurement and no use of over the
             counter Non-Steroidal Anti-Inflammatory Drug (NSAID) before the testing.

        Exclusion Criteria:

          1. Red flags identified during the subjects intake. If needling is contraindicated the
             subjects will be removed from the study and if necessary will be referred to an
             appropriate health care provider.

          2. Use of blood thinners

          3. History of surgery and or injury within the past six weeks

          4. Evidence of central nervous system involvement, to include hyperreflexia, sensory
             disturbances in the hand, intrinsic muscle wasting of the hands, unsteadiness during
             walking, nystagmus, loss of visual acuity, impaired sensation of the face, altered
             taste, the presence of pathological reflexes (i.e. positive Hoffman's and/or Babinski
             reflexes), etc.

          5. Prior surgery to the neck or thoracic spine

          6. Chiropractic, Physical Therapy, Dry needling or Acupuncture treatment for their neck
             pain in the last 3-months

          7. Inability to follow directions and keep the eye open during the measurement phase of
             this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rob Sillevis, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Integrated Therapy Practice PC</name>
      <address>
        <city>Hobart</city>
        <state>Indiana</state>
        <zip>46342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 29, 2018</study_first_submitted>
  <study_first_submitted_qc>November 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2018</study_first_posted>
  <last_update_submitted>November 1, 2018</last_update_submitted>
  <last_update_submitted_qc>November 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dry needling</keyword>
  <keyword>Autonomic nervous system</keyword>
  <keyword>pupillometry</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

